Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-25-000412
Filing Date
2025-03-18
Accepted
2025-03-18 16:17:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5863
  Complete submission text file 0001079973-25-000412.txt   7828
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Subject) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-80327 | Film No.: 25748590
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301
Business Address 3 ARIK EINSTEIN ST. B ENTRANCE HERZLIYA L3 4610301 927(0)779800501
S.H.N. Financial Investments Ltd. (Filed by) CIK: 0001890802 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SCHEDULE 13G